Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CITE

Cartica Acquisition (CITE) Stock Price, News & Analysis

Cartica Acquisition logo

About Cartica Acquisition Stock (NASDAQ:CITE)

Advanced Chart

Key Stats

Today's Range
$11.85
$11.85
50-Day Range
$11.68
$11.85
52-Week Range
$11.13
$11.85
Volume
407 shs
Average Volume
21,894 shs
Market Capitalization
$94.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cartica Acquisition Corp does not have any significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify and complete a business combination in the technology sector. Cartica Acquisition Corp was incorporated in 2021 and is based in New York, New York.

Receive CITE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cartica Acquisition and its competitors with MarketBeat's FREE daily newsletter.

CITE Stock News Headlines

CRTUF Cartica Acquisition Corp Units
Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.
Cartica Acquisition Corp (CITEW)
Cartica Acquisition Corp. Cl A
See More Headlines

CITE Stock Analysis - Frequently Asked Questions

Cartica Acquisition's top institutional investors include Mizuho Securities USA LLC (4.27%).

Based on aggregate information from My MarketBeat watchlists, some other companies that Cartica Acquisition investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), AI Transportation Acquisition (AITR), Alnylam Pharmaceuticals (ALNY), Alpha Star Acquisition (ALSA) and Amgen (AMGN).

Company Calendar

Today
5/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Trading
Current Symbol
NASDAQ:CITE
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
2,552,000
Market Cap
$94.80 million
Optionable
Not Optionable
Beta
0.01
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:CITE) was last updated on 5/12/2025 by MarketBeat.com Staff
From Our Partners